Citation Impact
Citing Papers
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype
2014
Abnormal Preantral Folliculogenesis in Polycystic Ovaries Is Associated with Increased Granulosa Cell Division
2007
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
Anti-cancer natural products isolated from chinese medicinal herbs
2011 Standout
Sheep models of polycystic ovary syndrome phenotype
2012
Development of polycystic ovary syndrome: involvement of genetic and environmental factors
2005
Follicle dynamics and anovulation in polycystic ovary syndrome
2008
Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility
2004
A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin
2008
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk
2012
A systematic review of tests predicting ovarian reserve and IVF outcome
2006
Stockpiling of Transitional and Classic Primary Follicles in Ovaries of Women with Polycystic Ovary Syndrome
2004
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries
2011
Use of letrozole in assisted reproduction: a systematic review and meta-analysis
2008
Pathophysiology of Polycystic Ovary Syndrome: The Role of Hyperandrogenism
2012
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Does PCOS have developmental origins?
2011
Protection of UV-induced Suppression of Skin Contact Hypersensitivity: A Common Feature of Flavonoids after Oral Administration?
1998
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome
2004
Carotenoids and human health
2007 Standout
DHEA, DHEAS and PCOS
2014
The management of patients with polycystic ovary syndrome
2014
Polycystic Ovaries Are Common in Women with Hyperandrogenic Chronic Anovulation but Do Not Predict Metabolic or Reproductive Phenotype
2005
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
2008
Is polycystic ovary syndrome an exception for reproductive aging?
2010
Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels
2010
Polycystic ovary syndrome and its developmental origins
2007
The biochemistry and medical significance of the flavonoids
2002 Standout
Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve
2009
Fertility and infertility: Definition and epidemiology
2018 Standout
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest
2004
Is foetal hyperexposure to androgens a cause of PCOS?
2017
Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome
2009
Reproductive endocrinology of adolescent polycystic ovary syndrome
2009
Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro
2010
Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin‐releasing hormone secretion
2009
The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome
2013
Polycystic Ovary Syndrome and Oocyte Developmental Competence
2008
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
Polycystic Ovary Syndrome
2005 Standout
Serum Anti-Müllerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome
2006
Photoprotection of UV-Irradiated Human Skin: An Antioxidative Combination of Vitamins E and C, Carotenoids, Selenium and Proanthocyanidins
2002
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
2013
Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
2016
Enhancement of the UVA induction of haem oxygenase‐1 expression by β‐carotene in human skin fibroblasts
1999
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing
2008
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Relationship Between Anti-Müllerian Hormone (AMH) and Insulin Levels During Different Tanner Stages in Daughters of Women With Polycystic Ovary Syndrome
2012
Anti-Mullerian hormone (AMH): what do we still need to know?
2009
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
2009
Identifying Children at Risk for Polycystic Ovary Syndrome
2006
Polycystic ovary syndrome
2016 Standout
Polycystic ovary syndrome in adolescents
2008
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries
2012
Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters
2011
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Anti-Müllerian hormone and ovarian dysfunction
2008
The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot study
2005
Preservation of Fertility in Patients with Cancer
2009 Standout
Anti-Mullerian hormone: a new marker for ovarian function
2005
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.
1976 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Protection of UV‐induced Suppression of Skin Contact Hypersensitivity: A Common Feature of Flavonoids after Oral Administration?
1998
Pathogenesis and pathophysiology of endometriosis
2012 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Anti-MüLlerian Hormone as a Marker of Ovarian Reserve: An Update
2008
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2
2015
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Variations in the Pattern of Pubertal Changes in Boys
1970 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Polycystic ovary syndrome
2013
State-of-the-science of endocrine disrupting chemicals, 2012
2012
Interrelationships between Ovarian and Pituitary Hormones in Ovulatory Menstrual Cycles across Reproductive Age
2008
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
Prevalence of Polycystic Ovary Syndrome in Women from Opposite-Sex Twin Pairs
2009
Linkage of regulators of TGF‐β activity in the fetal ovary to polycystic ovary syndrome
2011
Circulating AMH Reflects Ovarian Morphology by Magnetic Resonance Imaging and 3D Ultrasound in 121 Healthy Girls
2014
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Characterization of Functionally Typical and Atypical Types of Polycystic Ovary Syndrome
2009
The Halogen Bond
2016 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics
2016
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Works of Lisa Webber being referenced
Formation and early development of follicles in the polycystic ovary
2003
Disordered follicle development in ovaries of prenatally androgenized ewes
2007
Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters
2011
Anti-Mullerian Hormone Protein Expression Is Reduced during the Initial Stages of Follicle Development in Human Polycystic Ovaries
2005
Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
2008
Dietary β-carotene and ultraviolet-induced immunosuppression
1996
Prolonged Survival in Culture of Preantral Follicles from Polycystic Ovaries
2007